People · Operator
Named in public records as an officer, director or promoter · active 2022–2025 · Biotech / Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Ensysce Biosciences, Inc. | — | Biotech / Pharma | Series A | $25.4M | $7.9M | 2022 |
Lee Lynn Rauch at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Lee Lynn Rauch on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Andrew Lynn Benton | 1 | 1 |
| Curtis Lynn Rosebraugh | 1 | 1 |
| William Lynn Chang | 1 | 1 |
| Bob Lynn Gower | 1 | 1 |
| Steve Lynn Martin | 1 | 1 |
| David Lynn Humphrey | 1 | 1 |
| Adam Lynn Levin | 1 | 1 |
| D Lynn Kirkpatrick | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.